Dr. Vince Brandys graduated from DePaul University and the Illinois College of Optometry. He began a cold start private practice in the Northwest Suburbs of Chicago in 1993. Later he joined the administration of ICO in 2001 and held several adminstrative positions until his retirement in 2021.

During his optometric career, he has been a consultant for Alcon, Zeiss, Hoya, and several Ophthalmology practices in the Chicagoland area, as well as an expert witness for eye care litigation. Dr. Brandys has been a long-time volunteer for the Illinois and American Optometric Associations and state and federal lobbyist. He was elected President of the IOA in 2000 being the youngest OD ever to do so. The following year, the AOA recognized him as the national Young Optometrist of the Year.

Dr. Brandys is currently an associate in private practice in Lockport, IL and is the Principal Owner of Stingray Strategies, consulting firm for eye care industry clients.

Dr. Vince Brandys graduated from DePaul University and the Illinois College of Optometry. He began a cold start private practice in the Northwest Suburbs of Chicago in 1993. Later he joined the administration of ICO in 2001 and held several adminstrative positions until his retirement in 2021.

During his optometric career, he has been a consultant for Alcon, Zeiss, Hoya, and several Ophthalmology practices in the Chicagoland area, as well as an expert witness for eye care litigation. Dr. Brandys has been a long-time volunteer for the Illinois and American Optometric Associations and state and federal lobbyist. He was elected President of the IOA in 2000 being the youngest OD ever to do so. The following year, the AOA recognized him as the national Young Optometrist of the Year.

Dr. Brandys is currently an associate in private practice in Lockport, IL and is the Principal Owner of Stingray Strategies, consulting firm for eye care industry clients.

Dr. Vince Brandys graduated from DePaul University and the Illinois College of Optometry. He began a cold start private practice in the Northwest Suburbs of Chicago in 1993. Later he joined the administration of ICO in 2001 and held several administrative positions until his retirement in 2021.

During his optometric career, he has been a consultant for Alcon, Zeiss, Hoya, and several Ophthalmology practices in the Chicagoland area, as well as an expert witness for eye care litigation. Dr. Brandys has been a long-time volunteer for the Illinois and American Optometric Associations and state and federal lobbyist. He was elected President of the IOA in 2000 being the youngest OD ever to do so. The following year, the AOA recognized him as the national Young Optometrist of the Year.

Dr. Brandys is currently an associate in private practice in Lockport, IL and is the Principal Owner of Stingray Strategies, consulting firm for eye care industry clients.

Dr. Walid Mangal is a board-certified, fellowship-trained ophthalmologist with a sub-specialty in Vitreo-Retinal surgery. Dr. Mangal lectures and teaches about the MicroPulse Laser Technique and has used it to help thousands of patients.

Dr. Walid Mangal is a board-certified, fellowship-trained ophthalmologist with a sub-specialty in Vitreo-Retinal surgery. Dr. Mangal lectures and teaches about the MicroPulse Laser Technique and has used it to help thousands of patients.

Dr. Fishman was an undergraduate chemistry major and then earned a Ph.D. from Stanford in Chemistry and Neuroscience working in the area of lasers, microfluidics, and neuroscience. Dr. Fishman then conducted post-doctoral research Neurobiology working in the field of retinal ganglion cell nerve regeneration. He earned an M.D. from Stanford and after his medical internship, Dr. Fishman joined Stanford Ophthalmology both as an ophthalmology resident and faculty and founded the Ophthalmic Tissue Engineering Laboratory (OTEL). As director of OTEL. he was awarded one of the first BIO-X grants and became the founder of the artificial retina prosthesis project which has recently gone into clinical trials for patients with macular degeneration.

After completing his residency training in advanced eye surgery and medical treatment for eye diseases at Stanford, Dr. Fishman started his own concierge ophthalmology practice in Palo Alto where he continues to lead advancements in ocular surface disease and novel diagnostics for dry eye, cancer detection, and the ocular microbiome. Dr. Fishman has a special interest in digital health and has co-founded several silicon-valley start-ups.

Dr. Fishman has co-authored 34 Peer-reviewed Publications, 11 U.S. Patents, and his research has been highlighted in Scientific American, The Economist, JAMA, and Ophthalmology Times.

Alessio Fasano, MD, is the W. Allan Walker Chair of Pediatric Gastroenterology and Nutrition and Chief of the Division of Pediatric Gastroenterology and Nutrition at MassGeneral Hospital for Children. His visionary research, which established the rate of celiac disease at one in 133 people, led to the awareness of celiac disease as a growing public health problem in the United States. Dr. Fasano founded the Center for Celiac Research and Treatment in 1996, where he treats adults and children for gluten-related disorders.

Alessio Fasano, MD, is the W. Allan Walker Chair of Pediatric Gastroenterology and Nutrition and Chief of the Division of Pediatric Gastroenterology and Nutrition at MassGeneral Hospital for Children. His visionary research, which established the rate of celiac disease at one in 133 people, led to the awareness of celiac disease as a growing public health problem in the United States. Dr. Fasano founded the Center for Celiac Research and Treatment in 1996, where he treats adults and children for gluten-related disorders.

Dr. Bartlett is currently the vice president of global research and development for Pharmanex, where he oversees an energetic team of scientists, technicians and educators focused on innovation, research and development of new products. Dr. Bartlett is a member of the Council for Responsible Nutrition Senior Scientific Advisory Council, The American Association of Immunologists and The New York Academy of Sciences.

Dr. Bartlett is currently the vice president of global research and development for Pharmanex, where he oversees an energetic team of scientists, technicians and educators focused on innovation, research and development of new products. Dr. Bartlett is a member of the Council for Responsible Nutrition Senior Scientific Advisory Council, The American Association of Immunologists and The New York Academy of Sciences.